3,499 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by EntryPoint Capital LLC

EntryPoint Capital LLC purchased a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,499 shares of the medical technology company's stock, valued at approximately $623,000.

Other institutional investors have also recently bought and sold shares of the company. HighTower Advisors LLC increased its position in shares of Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock worth $986,000 after acquiring an additional 66 shares in the last quarter. Hengehold Capital Management LLC boosted its stake in Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock worth $229,000 after purchasing an additional 88 shares during the period. Exchange Traded Concepts LLC increased its holdings in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after purchasing an additional 94 shares in the last quarter. Avior Wealth Management LLC raised its stake in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock valued at $38,000 after purchasing an additional 101 shares during the period. Finally, Isthmus Partners LLC lifted its holdings in shares of Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after purchasing an additional 105 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Remove Ads

Teleflex Stock Performance

NYSE TFX traded down $1.61 on Friday, hitting $137.76. 776,408 shares of the stock were exchanged, compared to its average volume of 579,236. The company has a market capitalization of $6.39 billion, a PE ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The business's fifty day moving average is $159.20 and its 200 day moving average is $190.36. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.99%. Teleflex's payout ratio is 95.77%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Royal Bank of Canada downgraded Teleflex from an "outperform" rating to a "sector perform" rating and decreased their price objective for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Wells Fargo & Company decreased their price target on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Truist Financial cut their price objective on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research report on Monday, March 3rd. Morgan Stanley reduced their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, March 5th. Finally, Piper Sandler reiterated a "neutral" rating and issued a $140.00 price target (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Teleflex has an average rating of "Hold" and a consensus target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.